Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Productive Syntheses of Privileged Scaffolds Inspired by the Recognition of a Diels-Alder Pattern Common to Three Classes of Natural Products.
Badarau E, Reddy KHV, Loudet A, Simon C, Trembleau L, Claerhout S, Pair E, Massip S, Breton P, Lesur B, Goldstein S, Fourquez JM, Henlin JM, Ghosez L. Badarau E, et al. Among authors: henlin jm. Chemistry. 2020 Dec 1;26(67):15477-15481. doi: 10.1002/chem.202002372. Epub 2020 Sep 17. Chemistry. 2020. PMID: 32428343
NPY receptor subtypes involved in the contraction of the proximal colon of the rat.
Félétou M, Rodriguez M, Beauverger P, Germain M, Imbert J, Dromaint S, Macia C, Bourrienne A, Henlin JM, Nicolas JP, Boutin JA, Galizzi JP, Fauchère JL, Canet E, Duhault J. Félétou M, et al. Among authors: henlin jm. Regul Pept. 1998 Sep 25;75-76:221-9. doi: 10.1016/s0167-0115(98)00072-x. Regul Pept. 1998. PMID: 9802413
Identification of the melatonin-binding site MT3 as the quinone reductase 2.
Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E, Boutin JA. Nosjean O, et al. Among authors: henlin jm. J Biol Chem. 2000 Oct 6;275(40):31311-7. doi: 10.1074/jbc.M005141200. J Biol Chem. 2000. PMID: 10913150 Free article.
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth.
Casara P, Davidson J, Claperon A, Le Toumelin-Braizat G, Vogler M, Bruno A, Chanrion M, Lysiak-Auvity G, Le Diguarher T, Starck JB, Chen I, Whitehead N, Graham C, Matassova N, Dokurno P, Pedder C, Wang Y, Qiu S, Girard AM, Schneider E, Gravé F, Studeny A, Guasconi G, Rocchetti F, Maïga S, Henlin JM, Colland F, Kraus-Berthier L, Le Gouill S, Dyer MJS, Hubbard R, Wood M, Amiot M, Cohen GM, Hickman JA, Morris E, Murray J, Geneste O. Casara P, et al. Among authors: henlin jm. Oncotarget. 2018 Apr 13;9(28):20075-20088. doi: 10.18632/oncotarget.24744. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29732004 Free PMC article.
11 results